The path from target to drug is not a direct one; many complex uncertainties, from the basic biological to the clinical physiological level, exist 1. Successful therapeutics have often been identified ...
Daniel Hallow, Scale-up Systems Ltd. In the pharmaceutical, fine and speciality chemicals sectors, the study and application of mechanistic kinetic modeling is surprisingly variable. Approaches to ...